|
Report Date : |
06.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
YEN CHEN MACHINERY CO., LTD. |
|
|
|
|
Registered Office : |
No.38, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
14.09.1970 |
|
|
|
|
Com. Reg. No.: |
29531512 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture and sales of Pharmaceutical Machines, etc |
|
|
|
|
No. of Employees : |
About 100 employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
No.38, Huaya 1st Rd., Gueishan Township,
Taoyuan County 333, Taiwan (R.O.C.) |
|
Supplied Address: |
|
|
Telephone Number: |
+886-3328-9396 |
|
Fax Number: |
Notes: Subject’s exact name and address are as above.
|
Credit Opinion: |
Subject was incorporated on
|
Name |
Subscription Shares |
|
Qingsan Liu |
1,211,277 |
|
Wensheng Zheng |
|
|
414,667 |
|
|
Qiongying Liu |
2,051,900 |
|
Chengquan Wu |
475,408 |
The information above
is that of subject’s major shareholders.
It is introduced that subject has assembly factory in Kunshan, China, while
the details are not disclosed.
Core
Management
Directors
|
1 |
|
|
Name |
Qingsan Liu |
|
Position |
Board Chairman
& Manger |
|
Date of
Appointment |
|
|
2 |
|
|
Name |
Wensheng Zheng |
|
Position |
Director &
Manager |
|
Date of
Appointment |
|
|
3 |
|
|
Name |
Qiongying Liu |
|
Position |
Director &
Manager |
|
Date of
Appointment |
|
|
4 |
|
|
Name |
Yihua Liu |
|
Position |
Manager |
|
Date of
Appointment |
|
|
5 |
|
|
Name |
Shihao Xu |
|
Position |
Manager |
|
Date of
Appointment |
|
|
6 |
|
|
Name |
Litu Shi |
|
Position |
Manager |
|
Date of
Appointment |
|
|
7 |
|
|
Name |
Qingyao Su |
|
Position |
Manager |
|
Date of
Appointment |
|
Personnel
Structure
|
Total Employees |
About 100 employees |
Offices
& Factories
|
|
Headquarters |
|
Add |
No.38, Huaya 1st Rd., Gueishan Township, Taoyuan County 333, Taiwan
(R.O.C.) |
Production
Information
l
Subject is a manufacturer of pharmaceutical machines
and it is introduced that subject has factories in Taiwan and the mainland of
China for production and assembly.
Purchase
Information
l
The major registered activities of subject:
|
1 |
Design, manufacture, sales and maintenance of all
kinds of machinery |
|
2 |
Manufacture, sales and maintenance of instruments |
|
3 |
Bidding service, price quoting and sales of
relevant products for domestic and overseas customers. |
|
4 |
Import and export business of above mentioned
relevant products |
l
Subject purchases both at home and abroad and
subject’s purchasing all depends on specific conditions and customers’ demands.
l
The subject is mainly engaged in sales of
pharmaceutical machines including solid
dosage line, pellet machine production line, syrup line, injection line,
oitment line, extraction & concentration turn key equipments.
l
Subject’s products are applied to pharma, food,
biotechnology, chemical, and cosmetic fields, etc
l
Subject’s products are both sold in domestic and
overseas market and subject exports to Europe,
America, Japan, South Korea, Russia, Austrialia, Africa, Middle East, South
Asia, and South East Asia, etc
l
Subject’s major customers are Wyeth, Novartis, Abbott, Boehringer
Ingelheim, GSK, Merck, Eli Lilly, Sankyo, Takeda, Eisai, Otsuka, YSP, Novast,
Sanofi-aventis, etc.
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase
|
Payment Terms |
Proportion |
|
|
Raw materials and components, etc |
COD, Credit Sales, etc |
100% |
Foreign Purchase
|
Payment Terms |
Proportion |
|
|
Raw materials and components, etc |
CBD, etc |
100% |
Sales
Domestic Markets
|
Sales Terms |
Proportion |
|
|
Pharmaceutical Machines |
CBD, etc |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Pharmaceutical Machines |
CBD, etc |
100% |
Subject has no obligations to disclose its financial statements to the third
party according to the relevant policy in Taiwan and the only source from which
we can obtain the information is the subject itself.
Subject declined to disclose its financials citing the grounds of
company’s confidentiality; from other source we can not obtain the relevant
information, either.
Subject declined to disclose its bank details; from other source we can
not obtain the relevant information, either.
Mortgage
No chattel mortgage record of subject has been
found within the recent 3 months.
Lawsuit
Up to date of
reporting, no existing or latent litigation of the subject has been found.
|
Department |
Sales department |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.56 |
|
|
1 |
Rs.85.52 |
|
Euro |
1 |
Rs.69.50 |
INFORMATION DETAILS
|
Report Prepared
by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.